Trial Profile
Phase I/II Study to Determine the Safety and Efficacy of Quercetin in COPD
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 19 Dec 2013
Price :
$35
*
At a glance
- Drugs Quercetin (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 19 Dec 2013 New trial record